Abstract
The filamentous fungus that causes Mucormycosis is a newly discovered angiogenic infection that is found in large quantities and is a member of the Zygomycete class's Mucorales order. In patients undergoing hematopoietic and allogeneic stem cell transplantation, after candidiasis and aspergillosis, mucormycosis has become the third most common invasive mycosis. Breathing in sporangiospores is a daily need. The remarkably low frequency of Mucorales members in nasal mucus indicates that airborne contamination is either minimal or mucociliary transport removes spores from airway mucus. In this review research, new approaches to assessing the relationships among the host, the fungus, and antifungal drugs are provided. Aerosols and other novel delivery methods might also aid in the treatment of mucormycosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
